Leading the Way in Life Science Technologies

GEN Exclusives

More »

Tutorials

More »
Feb 15, 2009 (Vol. 29, No. 4)

Modeling Ensemble Powers Systems Biology

Reverse Engineering/Forward Simulation Platform Reveals How Biomolecules Interact

  • Conclusion

    Systems biology is evolving to meet the needs of researchers and drug developers who must extract meaningful, applicable knowledge out of an overwhelming—and growing—amount of biological data.  Armed with a greater understanding of the complexity of disease, industry will be better positioned to populate development pipelines with more promising drug candidates and help make predictive, preventive, and personalized medicine a reality. 



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »